Boehringer Ingelheim announces comprehensive settlement of U.S. Pradaxa < sup > ® < /sup > (dabigatran etexilate) litigation

Boehringer Ingelheim announces comprehensive settlement of U.S. Pradaxa < sup > ® < /sup > (dabigatran etexilate) litigation

Source: Boehringer Ingelheim Corporate News - July 25, 2016 Category: Research Source Type: news